 Print previewpersonal data approved: 2023. XII. 01. | Publications |
2021
 from data base, 2023. XII. 01. |
Kocsis Béla, Gulyás Dániel, Szabó Dóra: Delafloxacin, finafloxacin, and zabofloxacin: Novel fluoroquinolones in the antibiotic pipeline, ANTIBIOTICS 10: (12) 1506
type of document: Journal paper/Review paper
number of independent citations: 14
language: English
URL |
2021
from data base, 2023. XII. 01. |
Kocsis Béla, Gulyás Dániel, Szabó Dóra: Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones, MICROORGANISMS 9: (2) 359
type of document: Journal paper/Review paper
number of independent citations: 22
language: English
URL |
2021
from data base, 2023. XII. 01. |
Stercz B, Farkas B. Ferenc, Tóth Á, Gajdács M, Domokos J, Horváth V, Ostorházi E, Makra N, Kocsis B, Juhász J, Ligeti B, Pongor S, Szabó D: The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15, SCIENTIFIC REPORTS 11: 6335
type of document: Journal paper/Article
number of independent citations: 5
language: English
URL |
2019
from data base, 2023. XII. 01. |
Domokos Judit, Damjanova Ivelina, Kristof Katalin, Ligeti Balazs, Kocsis Bela, Szabo Dora: Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Klebsiella pneumoniae ST11 High-Risk Clone and Recently Emerging ST307 Clone, FRONTIERS IN MICROBIOLOGY 10: 157
type of document: Journal paper/Article
number of independent citations: 15
language: English
URL |
2019
from data base, 2023. XII. 01. |
Kocsis Bela, Toth Akos, Gulyas Daniel, Ligeti Balazs, Katona Katalin, Rokusz Laszlo, Szabo Dora: Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 clone., JOURNAL OF MEDICAL MICROBIOLOGY 68: (3) pp. 336-338.
type of document:
number of independent citations: 16
language: English
URL |
2016
from data base, 2023. XII. 01. |
Kocsis B, Domokos J, Szabo D: Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin, ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS 15: (1) 34
type of document: Journal paper/Review paper
number of independent citations: 78
language: English
URL |
2014
from data base, 2023. XII. 01. |
Tóth A, Kocsis B, Damjanova I, Kristóf K, Jánvári L, Pászti J, Csercsik R, Topf J, Szabó D, Hamar P, Nagy K, Füzi M: Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β -lactamase, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 33: (5) pp. 837-843.
type of document: Journal paper/Article
number of independent citations: 34
language: English
URL |
2013
from data base, 2023. XII. 01. |
Kadar B, Kocsis B, Nagy K, Szabo D: The renaissance of polymyxins, CURRENT MEDICINAL CHEMISTRY 20: (30) pp. 3759-3773.
type of document: Journal paper/Review paper
number of independent citations: 38
language: English
URL |
2010
from data base, 2023. XII. 01. |
Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr: The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models., INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 35: (4) pp. 357-361.
type of document: Journal paper/Article
number of independent citations: 45
language: English
URL |
2008
from data base, 2023. XII. 01. |
Noto PB, Abbadessa G, Cassone M, Mateo GD, Agelan A, Wade JD, Szabo D, Kocsis B, Nagy K, Rozgonyi F, Otvos L Jr: Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo, PROTEIN SCIENCE 17: (7) pp. 1249-1255.
type of document: Journal paper/Article
number of independent citations: 42
language: English
URL |
| | Number of independent citations to these publications: | 309 |
|
|
Login
med.semmelweis-univ.hu
